The study shows that vaccination with two doses of recombinant zoster vaccine is associated with a 51% reduction in the risk of dementia in adults aged ≥65 years. Reduction in risk is comparable across subgroups and remains statistically significant after accounting for healthy vaccinee bias.
- Emily Rayens
- Lina S. Sy
- Hung Fu Tseng